Abstract:AIM:To study the transfection and anti-hepatitis B virus (HBV) effect of the co-modified hepatocytes-targeting cationic liposomes encapsulating anti-HBV antisense oligonucleotides (asON) , and to investigate the transfection mechanisms of the liposomes.METHODS:Dipalmitoylphosphatidylcholine (DPPC) and 3beta-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) were used as the lipids, beta-sitosterol-beta-D-glucoside (sito-G) and Brij 35 were used to modify the liposomes. Flow cytometry (FCM), fluorescence microscopy and enzyme-linked immunosorbent assay (ELISA) were utilized to evaluate the transfection improvement of the asON encapsulated in the liposomes in primary rat hepatocytes and the antigens inhibition activity in HepG 2.2.15 cells. The transfection mechanisms were evaluated based on the influence of wortmannin, nigericin, and asialofetuin on the antigens inhibition in HepG 2.2.15 cells by ELISA.RESULTS:The co-modification with sito-G and Brij 35 significantly improved the transfection of the liposomes in primary rat hepatocytes and antigens inhibition effect in HepG 2.2.15 cells. Both transfection efficiency and antigens inhibition effect showed to be concentration-dependent with the asON-encapsulating liposomes. In fluorescence microscopy, the transfected cells showed strong fluorescence in primary rat hepatocytes, especially in the nuclei. Wortmannin, nigericin and asialofetuin decreased the antigens inhibition of the asON-encapsulating liposomes to different levels. Cationic liposomes modification with sito-G and Brij 35 could improve the transfection and antigens inhibition effect of the asON. The transfection mechanisms of the co-modified liposomes included endocytosis and membrane fusion. The ligand sito-G was confirmed to be able to enhance asialoglycoprotein receptor (ASGPR)-mediated endocytosis.CONCLUSION:Co-modified hepatocytes-targeting cationic liposomes would be a specific and effective carrier to transfer asON into hepatocytes.

[Liver Targeting of Cationic Liposomes Modified with Soybean-Derived Sterylglucoside in Vitro].

Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol

[Biodistribution and Hepatocytes Targeting of Cationic Liposomes Surface-Modified with Sterylglucoside and Golyethylene Glycol].

Liver-targeted Resveratrol Liposome

Preparation of Liposomes Surface-modified with Glycyrrhetinic Acid Targeting to Hepatocytes

Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.

Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell–Targeting Effect

Construction of a Visualized Liver-Targeting Sirna Delivery System

[Transfection and Anti-Hbv Effect Mediated by the Hepatocytes-Targeting Cationic Liposomes Co-Modified with Beta-Sitosterol-beta-d-glucoside and Brij 35].

Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.

[In Vitro Targeting Effect of Lactoferrin Modified PEGylated Liposomes for Hepatoma Cells].

Preparation, Characterization and Uptake by Primary Cultured Rat Hepatocytes of Liposomes Surface-Modified with Glycyrrhetinic Acid.

Glycyrrhetinic Acid-Modified Chitosan/poly(ethylene Glycol) Nanoparticles for Liver-Targeted Delivery

Preparation of glycyrrhizic acid-modified BSA-nanoparticles and evaluation of their hepatic cellular distribution

Characteristics and Biodistribution of Soybean Sterylglucoside and Polyethylene Glycol-Modified Cationic Liposomes and Their Complexes with Antisense Oligodeoxynucleotide

Liver Targeting of Galactosylated Liposome-Polycation-dna Complexes

Galangin-loaded, Liver Targeting Liposomes: Optimization and Hepatoprotective Efficacy

Preparation, in Vitro and in Vivo Evaluation of Isoliquiritigenin-Loaded TPGS Modified Proliposomes.

Preparation and Evaluation of N-Caproyl Chitosan Nanoparticles Surface Modified with Glycyrrhizin for Hepatocyte Targeting

[Influence of Soybean-Derived Sterylglucoside and Amphipathic Polyethylene Glycol on the Cellular Delivery and Anisotropy of Different Cationic Liposomes].

Hepatocellular Carcinoma Targeting Effect of PEGylated Liposomes Modified with Lactoferrin.